ethinyl estradiol; norethindrone acetate · Millicent Mfg Pr · NDA 218718
Femlyv
Earliest generic entry, as listed
24 Jun 2041
Blocked by patent: US 12178824.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12178824 | drug product · sets the listed date | 24 Jun 2041 |
Exclusivities · 1 unexpired
| NP | new product | 22 Jul 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 218718 · 001 · RLD | tablet, orally disintegrating, oral | 0.02MG;1MG | 24 Jun 2041 |